Crea il mio profilo
Accesso pubblico
Visualizza tutto21 articoli
0 articoli
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
- Ebba SohlbergPhD, Karolinska InstitutetEmail verificata su ki.se
- Eivind Heggernes AskUniversity of Oslo, Oslo University HospitalEmail verificata su uio.no
- Vincent, Yi Sheng OeiUniversity of Oslo / Duke-NUS Medical SchoolEmail verificata su u.duke.nus.edu
- Trevor ClancyCo-founder at NEC OncoImmunity. Professor at Nagasaki UniversityEmail verificata su oncoimmunity.com
- Quirin HammerTeam leader, Karolinska InstitutetEmail verificata su ki.se
- Björn ÖnfeltDepartment of Applied Physics, KTH Royal Institute of TechnologyEmail verificata su scilifelab.se
- Hans-Gustaf LjunggrenProfessor, Karolinska InstitutetEmail verificata su ki.se
- Aline PfefferleKarolinska InstituteEmail verificata su ki.se
- Béziat VivienInstitut ImagineEmail verificata su inserm.fr
- Kjetil TaskenProfessor of Medicine, Univ. of Oslo & Head, Institute of Cancer Research, Oslo University HospitalEmail verificata su medisin.uio.no
- Sandip PatelProfessorEmail verificata su ucl.ac.uk
- Herman NetskarUniversity of OsloEmail verificata su uio.no
- Melissa M. Berrien-ElliottSaint Louis University School of MedicineEmail verificata su health.slu.edu
- Ravi VijWashington UniversityEmail verificata su wustl.edu
- Jeff LeongWashington University School of MedicineEmail verificata su wusm.wustl.edu
- Todd A Fehniger MD/PhDProfessor of Medicine, Division of Oncology, Washington University School of Medicine in St. LouisEmail verificata su wustl.edu
- Maximillian RosarioJohns HopkinsEmail verificata su jhmi.edu
- Rizwan Romee, MDDana Farber Cancer Institute, Harvard Medical SchoolEmail verificata su dfci.harvard.edu
- Sten LinnarssonProfessor, Karolinska InstitutetEmail verificata su ki.se
- William LouchProfessor of Medicine, University of OsloEmail verificata su medisin.uio.no
Segui
Jode Goodridge
Altri nomiJodie Peter Goodridge
Fate Therapeutics
Email verificata su fatetherapeutics.com